Orthopedic Executives Remain Bullish on New Tech and ASCs
We round up third-quarter commentary from orthopedic executives as they focus on market expansion, technology, ASCs and staffing. Dec 06, 2022
Orthopedic Market 2022 Projections & 2023 Outlook
The webinar provides 2022 projections for orthopedic market segments and top players as well as expected 2023 market forces. Nov 28, 2022
Medtronic Offsets VBP with Strength in U.S.
The company's orthopedic sales grew in the mid-single-digits for FY 2Q23 on the strength of core spine and enabling technology in the U.S. Nov 28, 2022
ZimVie Sees Substantial Opportunity in Enabling Technology
The company declined in the mid-teens for 3Q22 as it works through its transformation but sees unmet needs that enabling tech could address. Nov 22, 2022
Bioventus Lowers 2022 Guidance, Pauses M&A
The company's 3Q22 orthopedic revenue grew more than 20% but changes to viscosupplement reimbursement will be a headwind through 1H23. Nov 22, 2022
Chart of the Month: Knee and Hip Recovery Trends
This month’s chart examines the knee and hip replacement sales for the big four players from the beginning of 2019 through 3Q22. Nov 22, 2022
Ortho Market Pressures Moderated in 3Q, Year-End Surge Unlikely
We estimate the orthopedic market grew in the low single-digits as procedure volumes recovered across most categories. Nov 21, 2022
Anika Remains On Track For 2022 Guidance
The company grew below 1% in 3Q22 due to a difficult prior year comparison, supply chain headwinds and slowly recovering elective procedures. Nov 17, 2022
SI-BONE Set for Reimbursement Tailwinds
The company grew more than 18% in 3Q22 and will benefit from substantial CMS fee increases in ASCs for 2023. Nov 15, 2022
NuVasive Focused on Long Term Growth Strategy
The company grew in high single-digits for 3Q22 on the strength of case volume recovery and its portfolio of procedural solutions. Nov 14, 2022
